Free tool
FAERS Monitor: Virazole
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018859 or its brand name (Virazole, Ribavirin). Reports on generic versions are filed under their own applications.
Reports
63,955
Serious
37,984
59% of reports
Hospitalization
14,154
Death reported
3,419
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue9,564
- anaemia8,370
- nausea7,440
- rash5,358
- headache4,795
- pruritus4,647
- vomiting3,810
- diarrhoea3,751
- asthenia3,618
- pyrexia3,583
- white blood cell count decreased3,443
- insomnia3,439
- dyspnoea3,339
- decreased appetite3,275
- drug ineffective3,224
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 392 |
| 2005 | 622 |
| 2006 | 686 |
| 2007 | 920 |
| 2008 | 1,230 |
| 2009 | 1,196 |
| 2010 | 964 |
| 2011 | 1,403 |
| 2012 | 13,701 |
| 2013 | 9,239 |
| 2014 | 4,843 |
| 2015 | 13,685 |
| 2016 | 5,553 |
| 2017 | 2,869 |
| 2018 | 2,639 |
| 2019 | 1,485 |
| 2020 | 815 |
| 2021 | 505 |
| 2022 | 417 |
| 2023 | 236 |
| 2024 | 268 |
| 2025 | 178 |
| 2026 | 104 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,990,204 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anaemiaSignal | 8,370 | 15.0 | 14.7 | 105,907 |
| white blood cell count decreasedSignal | 3,443 | 10.8 | 10.4 | 29,642 |
| decreased appetiteSignal | 3,275 | 4.7 | 4.5 | 9,472 |
| insomniaSignal | 3,439 | 4.3 | 4.2 | 8,667 |
| rashSignal | 5,358 | 4.1 | 4.0 | 12,563 |
| fatigueSignal | 9,564 | 4.1 | 4.0 | 22,784 |
| pruritusSignal | 4,647 | 4.0 | 3.9 | 10,576 |
| pyrexiaSignal | 3,583 | 3.4 | 3.3 | 6,206 |
| astheniaSignal | 3,618 | 3.2 | 3.1 | 5,468 |
| nauseaSignal | 7,440 | 3.1 | 3.0 | 10,970 |
| vomitingSignal | 3,810 | 2.7 | 2.6 | 4,065 |
| headacheSignal | 4,795 | 2.5 | 2.5 | 4,523 |
| dyspnoea | 3,339 | 1.9 | 1.9 | 1,566 |
| diarrhoea | 3,751 | 1.9 | 1.9 | 1,685 |
| drug ineffective | 3,224 | 0.8 | 0.8 | 164 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.